ASCO Guidelines cover image

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.3 Part 2

ASCO Guidelines

00:00

Implementing New Recommendations for Stage IV NSCLC With Driver Alterations

Exploring the importance of biomarker testing and shared decision-making in treating Stage IV NSCLC with driver alterations, including managing delays and the role of chemotherapy while awaiting sequencing results.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app